Cultured autologus epithelia grafting for treating vitiligo: Results in 5 cases

H. Ohshima, N. Kumagai, K. Matsuzaki, S. Fukushi, M. Tanabe, H. Ishida, T. Uchikoshi

Research output: Contribution to journalArticle

Abstract

Vitiligo, which is histologically characterized by the absence of epidermal melanocytes, is manifested as irregular depigmented macules of the skin that can vary in size from minute to large in any area of the body. Patients with vitiligo are mainly treated with psoralens and ultraviolet A (PUVA) or corticosteroids, singly or in combination, but the results of these therapies are occassionally disappointing and, for some cases, ineffective. Thus, in the search for better vitiligo therapies, clinical trials have been conducted using autografts, such as a punch graft, minigrafts, or an epidermal graft, and while these grafts have induced skin repigmentation, the appearance is often uneven and spotty and flawed by unsightly scarring. To avoid scarring, we have tried another approach using cultured autologus epithelia grafting, first reported by Todd in 1989, in 5 patients with vitiligo and have achieved considerable repigmentation, ranging from 30 to 95% of the graft. The reason for this pigmentation inconsistency is thought due to the state of the vitiligo, which in some patients was still active. We thus have concluded that cultured autologus epithelia transplantation may hold promise as a treatment method for patients with inactive vitiligo.

Original languageEnglish
Pages (from-to)161-169
Number of pages9
JournalJapanese Journal of Plastic and Reconstructive Surgery
Volume39
Issue number2
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Vitiligo
Epithelium
Transplants
Cicatrix
Skin
Melanocytes
Autografts
Pigmentation
Adrenal Cortex Hormones
Therapeutics
Transplantation
Clinical Trials

ASJC Scopus subject areas

  • Surgery

Cite this

Ohshima, H., Kumagai, N., Matsuzaki, K., Fukushi, S., Tanabe, M., Ishida, H., & Uchikoshi, T. (1996). Cultured autologus epithelia grafting for treating vitiligo: Results in 5 cases. Japanese Journal of Plastic and Reconstructive Surgery, 39(2), 161-169.

Cultured autologus epithelia grafting for treating vitiligo : Results in 5 cases. / Ohshima, H.; Kumagai, N.; Matsuzaki, K.; Fukushi, S.; Tanabe, M.; Ishida, H.; Uchikoshi, T.

In: Japanese Journal of Plastic and Reconstructive Surgery, Vol. 39, No. 2, 1996, p. 161-169.

Research output: Contribution to journalArticle

Ohshima, H, Kumagai, N, Matsuzaki, K, Fukushi, S, Tanabe, M, Ishida, H & Uchikoshi, T 1996, 'Cultured autologus epithelia grafting for treating vitiligo: Results in 5 cases', Japanese Journal of Plastic and Reconstructive Surgery, vol. 39, no. 2, pp. 161-169.
Ohshima H, Kumagai N, Matsuzaki K, Fukushi S, Tanabe M, Ishida H et al. Cultured autologus epithelia grafting for treating vitiligo: Results in 5 cases. Japanese Journal of Plastic and Reconstructive Surgery. 1996;39(2):161-169.
Ohshima, H. ; Kumagai, N. ; Matsuzaki, K. ; Fukushi, S. ; Tanabe, M. ; Ishida, H. ; Uchikoshi, T. / Cultured autologus epithelia grafting for treating vitiligo : Results in 5 cases. In: Japanese Journal of Plastic and Reconstructive Surgery. 1996 ; Vol. 39, No. 2. pp. 161-169.
@article{522b97611d1d42ecbefdc3c57da59a0f,
title = "Cultured autologus epithelia grafting for treating vitiligo: Results in 5 cases",
abstract = "Vitiligo, which is histologically characterized by the absence of epidermal melanocytes, is manifested as irregular depigmented macules of the skin that can vary in size from minute to large in any area of the body. Patients with vitiligo are mainly treated with psoralens and ultraviolet A (PUVA) or corticosteroids, singly or in combination, but the results of these therapies are occassionally disappointing and, for some cases, ineffective. Thus, in the search for better vitiligo therapies, clinical trials have been conducted using autografts, such as a punch graft, minigrafts, or an epidermal graft, and while these grafts have induced skin repigmentation, the appearance is often uneven and spotty and flawed by unsightly scarring. To avoid scarring, we have tried another approach using cultured autologus epithelia grafting, first reported by Todd in 1989, in 5 patients with vitiligo and have achieved considerable repigmentation, ranging from 30 to 95{\%} of the graft. The reason for this pigmentation inconsistency is thought due to the state of the vitiligo, which in some patients was still active. We thus have concluded that cultured autologus epithelia transplantation may hold promise as a treatment method for patients with inactive vitiligo.",
author = "H. Ohshima and N. Kumagai and K. Matsuzaki and S. Fukushi and M. Tanabe and H. Ishida and T. Uchikoshi",
year = "1996",
language = "English",
volume = "39",
pages = "161--169",
journal = "Japanese Journal of Plastic Surgery",
issn = "0021-5228",
publisher = "Kokuseido Publishing Co. Ltd",
number = "2",

}

TY - JOUR

T1 - Cultured autologus epithelia grafting for treating vitiligo

T2 - Results in 5 cases

AU - Ohshima, H.

AU - Kumagai, N.

AU - Matsuzaki, K.

AU - Fukushi, S.

AU - Tanabe, M.

AU - Ishida, H.

AU - Uchikoshi, T.

PY - 1996

Y1 - 1996

N2 - Vitiligo, which is histologically characterized by the absence of epidermal melanocytes, is manifested as irregular depigmented macules of the skin that can vary in size from minute to large in any area of the body. Patients with vitiligo are mainly treated with psoralens and ultraviolet A (PUVA) or corticosteroids, singly or in combination, but the results of these therapies are occassionally disappointing and, for some cases, ineffective. Thus, in the search for better vitiligo therapies, clinical trials have been conducted using autografts, such as a punch graft, minigrafts, or an epidermal graft, and while these grafts have induced skin repigmentation, the appearance is often uneven and spotty and flawed by unsightly scarring. To avoid scarring, we have tried another approach using cultured autologus epithelia grafting, first reported by Todd in 1989, in 5 patients with vitiligo and have achieved considerable repigmentation, ranging from 30 to 95% of the graft. The reason for this pigmentation inconsistency is thought due to the state of the vitiligo, which in some patients was still active. We thus have concluded that cultured autologus epithelia transplantation may hold promise as a treatment method for patients with inactive vitiligo.

AB - Vitiligo, which is histologically characterized by the absence of epidermal melanocytes, is manifested as irregular depigmented macules of the skin that can vary in size from minute to large in any area of the body. Patients with vitiligo are mainly treated with psoralens and ultraviolet A (PUVA) or corticosteroids, singly or in combination, but the results of these therapies are occassionally disappointing and, for some cases, ineffective. Thus, in the search for better vitiligo therapies, clinical trials have been conducted using autografts, such as a punch graft, minigrafts, or an epidermal graft, and while these grafts have induced skin repigmentation, the appearance is often uneven and spotty and flawed by unsightly scarring. To avoid scarring, we have tried another approach using cultured autologus epithelia grafting, first reported by Todd in 1989, in 5 patients with vitiligo and have achieved considerable repigmentation, ranging from 30 to 95% of the graft. The reason for this pigmentation inconsistency is thought due to the state of the vitiligo, which in some patients was still active. We thus have concluded that cultured autologus epithelia transplantation may hold promise as a treatment method for patients with inactive vitiligo.

UR - http://www.scopus.com/inward/record.url?scp=0029927856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029927856&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029927856

VL - 39

SP - 161

EP - 169

JO - Japanese Journal of Plastic Surgery

JF - Japanese Journal of Plastic Surgery

SN - 0021-5228

IS - 2

ER -